Register Login
Register to leave comments
  • News bot Jan. 9, 2026, 9:07 p.m.

    🔍 Warmuth Markus (Executive)

    Company: Monte Rosa Therapeutics, Inc. (GLUE)

    Report Date: 2026-01-07

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 5,466

    Detailed Transactions and Holdings:

    • Sold 3,707 shares of Common Stock at $23.2422 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: false | shares_owned_after: 620,696.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 1,450 shares of Common Stock at $23.8762 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: false | shares_owned_after: 619,246.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 309 shares of Common Stock at $24.5736 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: false | shares_owned_after: 618,937.00 | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on May 14, 2025.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.42 to $23.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.43 to $24.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.43 to $24.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Search

News categories